Vaccinating Children against COVID-19: Commentary and Mathematical Modeling-Reference-Cited by-同舟云学术

Vaccinating Children against COVID-19: Commentary and Mathematical Modeling

Published:2022-02-22 Issue:1 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Hawkes Michael T.¹²³⁴⁵^ORCID,Good Michael F.⁶⁷

Affiliation:

1. Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada

2. Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada

3. School of Public Health, University of Alberta, Edmonton, Alberta, Canada

4. Distinguished Researcher, Stollery Science Lab, University of Alberta, Edmonton, Alberta, Canada

5. Member, Women and Children's Research Institute, University of Alberta, Edmonton, Alberta, Canada

6. Institute for Glycomics, Griffith University, Gold Coast, Australia

7. University of Alberta, Edmonton, Canada

Abstract

Countries have recently begun implementation of childhood vaccination against SARS-CoV-2 with the Pfizer/BioNTech mRNA vaccine in children 5 to 11 years of age. Because SARS-CoV-2 disease severity is remarkably age dependent, vaccinating children may have modest public health benefits, relative to the unequivocal benefit of vaccinating vulnerable older adults.

Funder

Women and Children's Health Research Institute

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.03789-21

Reference24 articles.

1. Assessing relative COVID-19 mortality: a Swiss population-based study

2. Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States

3. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data